VillageMD CEO Tim Barry steps down
Barry has left VillageMD during a difficult time for the value-based medical group, which has dragged down the finances of majority owner Walgreens.
Uncategorized
Hospices owned by private equity firms underperform nonprofit facilities, study says
The JAMA study comes as federal regulators scrutinize private equity’s role in healthcare.
Hospices owned by private equity firms underperform nonprofit facilities, study says Read More »
J&J appoints Shawn Millerick to lead vision care unit in the Americas
Millerick, who spent time at Abbott and Alcon, is responsible for defining strategy and driving growth at a J&J business that sells products including Acuvue contact lenses.
J&J appoints Shawn Millerick to lead vision care unit in the Americas Read More »
Guardant awarded nearly $293M in false ad trial against Natera
Natera allegedly made “false and misleading statements” to convince people to use its Signatera cancer test rather than Guardant’s rival product Reveal.
Guardant awarded nearly $293M in false ad trial against Natera Read More »
Novartis Pays Up to $2.9B in Huntington’s Deal With PTC
Monday’s agreement comes days after PTC discontinued the development of another asset, utreloxastat, due to disappointing Phase II data in amyotrophic lateral sclerosis.
Novartis Pays Up to $2.9B in Huntington’s Deal With PTC Read More »
Colisée: residencias de calidad para el cuidado de personas mayores
El cuidado de nuestros mayores es uno de los objetivos principales de cualquier familia. Procurarles la atención que precisan y hacerles más dignos y plácidos los últimos tramos de su camino ha de ser una prioridad. Sin embargo, no siempre se pueden dispensar es …
Colisée: residencias de calidad para el cuidado de personas mayores Read More »
AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024
At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus will reveal promising mid-stage data for their respective cancer candidates.
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug Read More »
Bluebird’s Gene Therapy Skysona Under FDA Safety Probe for Hematologic Malignancies
The cancers were diagnosed 19 to 92 months after Skysona treatment.
Bluebird’s Gene Therapy Skysona Under FDA Safety Probe for Hematologic Malignancies Read More »
Determinan en qué punto de Europa se fabricaron las primeras herramientas de piedra avanzadas conocidas del continente
Un estudio ha identificado evidencias de comportamientos tecnológicos avanzados en las herramientas de piedra fabricadas por los homininos hace entre 900.000 y 780.000 años en el yacimiento del Barranc de la Boella (La Canonja, Tarragona, Cataluña). El estudio lo han realizado e …